Education Track Session

Preparing for Change: Key Regulatory and Legislative Updates for Home and Alternate Site Infusion Providers

The regulatory and policy environment for home and alternate site infusion providers continues to evolve rapidly, creating both challenges and opportunities for providers, suppliers, and stakeholders. This session will provide an in-depth review of the most significant federal legislative, reimbursement, and regulatory developments impacting infusion care in 2026 and beyond.
The regulatory and policy environment for home and alternate site infusion providers continues to evolve rapidly, creating both challenges and opportunities for providers, suppliers, and stakeholders. This session will provide an in-depth review of the most significant federal legislative, reimbursement, and regulatory developments impacting infusion care in 2026 and beyond.

Learning Objectives

  • Assess the impact of IRA Medicare drug price negotiation policies on home and alternate site infusion providers.
  • Evaluate DMEPOS policy changes, including implementation considerations related to the Fiandra.
  • Identify operational, compliance, and advocacy strategies to prepare for upcoming regulatory and legislative changes.
  • Speaker(s)

    Bill Noyes  SVP of Reimbursement Policy
    NHIA

                array(6) {
      [0]=>
      string(17) "Session Organizer"
      [1]=>
      string(19) "Symposium Organizer"
      [2]=>
      string(22) "Learning Lab Organizer"
      [3]=>
      string(13) "ISC Organizer"
      [4]=>
      string(16) "Industry Contact"
      [5]=>
      string(17) "Theater Organizer"
    }
                
    Speaker

    Share: